Pfizer Inc. has agreed to pay $43 billion for biotech Seagen Inc. and its pioneering class of targeted cancer drugs.
Under the terms, Pfizer would pay $229 a share in cash, the drugmaker said Monday. The companies expect the deal, which includes debt, to close late this year or early next year.
Continue reading your article with
a WSJ subscription
Already a member? Sign In
Sponsored Offers
- Target:
Target Promo Code: 20% Off Entire Order - Vitacost:
Get 20% off on Probar products when you shop 3 items - Walmart:
Walmart promo code 2023 – $20 off $50 - Groupon:
Groupon Promo Code – 30% Off - adidas:
adidas Promo Code – 25% Off Sitewide - Nike:
60% off running shoes and apparel at Nike without a promo code